An early phase 2 study of NST-141 in patients with atopic dermatitis

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221375

Enrollment

120

Registered

2011-02-08

Start date

2011-02-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pruritus associated with atopic dermatitis

Interventions

investigational material(s) Generic name etc : NST-141 ointment 1% INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Signed, written informed consent. (2) Able to be treated as an outpatient. (3) Diagnosis of atopic dermatitis by Japanese dermatological association criteria.

Exclusion criteria

Exclusion criteria: (1) Serious asthma. (2) Hepatic, renal, heart or hematological disease considered to be clinically significant by the Investigator's opinion. (3) Infection of skin with antimicrobial use.

Design outcomes

Primary

Measure	Time frame
Change in levels of pruritus	—

Secondary

Measure	Time frame
Pruritus score	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026